← All indications
Pulmonary Aspergillosis
Infections of the respiratory tract with fungi of the genus ASPERGILLUS.
Subtype terms (2)
More specific conditions that are subtypes of Pulmonary Aspergillosis in the MeSH hierarchy.
- Aspergillosis, Allergic Bronchopulmonary
15 drugs (14 approved, 1 experimental)
- Invasive Pulmonary Aspergillosis
9 drugs (7 approved, 2 experimental)
Drugs by status
Phase 2 trials (1)
Organizations
Organization Involved with Phase 4 Indications (15)
- Merck
- Novartis
- Baylor University
- First People's Hospital of Hangzhou
- Guangzhou Medical University
- Postgraduate Institute of Medical Education and Research
- Red Cross Hospital, Hangzhou, China
- Capital Medical University
- Zhejiang University
- Ningbo No. 5 Hospital
- Hangzhou Red Cross Hospital
- Hangzhou Hospital of Traditional Chinese Medicine
- Second People's Hospital of Hangzhou
- Xiaoshan People's Hospital
- Huzhou University
Organization Involved with Phase 3 Indications (8)
Organization Involved with Phase 2 Indications (13)
Organization Involved with Phase 1 Indications (3)
Organization Involved with Other Experimental Indications (2)